English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 28, 2026

Study finds melatonin reduces inflammation in fetal membranes linked to preterm birth

+ Pharmaceuticals
Patient Daily | Jun 28, 2026

Bedside eye test may help predict consciousness recovery after brain injury, study finds

+ Pharmaceuticals
Patient Daily | Jun 27, 2026

Gene fusion patterns refine classification of rare acute leukemias

+ Pharmaceuticals
Patient Daily | Jun 27, 2026

Florida grant funds new program to support cancer survivors’ health and well-being

+ Pharmaceuticals
Patient Daily | Jun 27, 2026

Women's health providers increased political activity after Dobbs decision, study finds

+ Pharmaceuticals
Patient Daily | Jun 27, 2026

Gene therapy for rare immune disorder advances after promising pre-clinical studies

+ Pharmaceuticals
Patient Daily | Jun 27, 2026

Adelaide University trial tests new treatment for retinitis pigmentosa blindness

+ Pharmaceuticals
Patient Daily | Jun 27, 2026

Framework proposed for sustainable digital pathology implementation in clinical practice

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily